cdmo.directory
← Compare landing

Galenvs Sciences vs TriLink BioTechnologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/galenvs-sciences/trilinkbiotech

CategoryGalenvs SciencesTriLink BioTechnologies
Listed sitecdmocdmo
SummaryGalenvs makes modified, specialty oligonucleotides for drug and gene-therapy programs, from proof of concept to pilot scale, under an ISO 9001:2015 certified quality system.TriLink manufactures mRNA, oligonucleotides, and modified nucleotides with proprietary CleanCap® capping technology achieving >95% Cap1 efficiency, supported by in-house analytical method development and a 118,000 sq ft GMP-capable facility.
Services
  • Oligonucleotide Manufacturing
  • Process Development
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Process Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
Modalities
  • Oligonucleotide
  • mRNA
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Montréal, Québec, Canada
  • Headquarters
Certifications
  • ISO · Identifier: ISO 9001:2015
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.